How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Welcome to this afternoon session with Recursion. My name is Andrew Pucher. I'm part of the Healthcare Investment Banking team, and I'm joined by Ben Taylor, CFO of Recursion; and Sara Sherman, Head ...

A geographical oddity recently discovered in the remote northern regions of Canada has left social media users reeling. The unique structure, which appears to be the world’s largest ...

Doctors could not say if two-week-old baby Henry had arrived near his due date because his mother Charlotte had no idea she was carrying him A woman said she had no idea she was pregnant until she ...

September’s new restaurant openings have a common theme: they want you to open your wallet. Are you ready for a $218 fish or a $300 tasting? Come right in. Looking for a fun new $15 lunch? Maybe stay ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...